Legal News

The MJH Life Sciences™ COVID-19 Coalition is hosting a live webinar event on the legal and ethical considerations of COVID-19 vaccination.

SCOTUS' decision upholds an Arkansas law regulating PBMs’ drug reimbursement rates.

The Department of Health and Human Services recently released a final rule requiring health insurers to disclose drug pricing and cost-sharing information

Following the 2020 election, pharmacy groups welcomed the newly elected pharmacist congressmembers and commented on pharmacy issues requiring attention from Congress.

Guest host Brian Nightengale, president of Good Neighbor Pharmacy, is joined by Rich Tremonte and Doug Hoey to discuss the biggest opportunities and headwinds facing independent pharmacies in 2021.

Todd Mizeski, Esq, a Partner in Frier Levitt’s Life Sciences, Litigation Department, discusses the case of Rutledge v. Pharmaceutical Care Management Association.

Walmart filed a pre-emptive suit against 2 government agencies that are threatening to sue Walmart over its pharmacists filling opioid prescriptions.

The new guidance provides clarification on requirements for pharmacy interns and technicians to administer childhood and COVID-vaccines, as well as COVID-19 tests.

Bill SB 852 would address the affordability and accessibility of generic drugs, including insulin and epinephrine, in California.

Rutledge v. Pharmaceutical Care Management Association seeks to clarify whether states can regulate pharmacy benefit managers.

What happens next in health care depends largely on COVID-19, especially in light of the breaking news that the President has been diagnosed with COVID-19. And then, of course, on the 2020 presidential election itself.

The FDA’s final rule allows the importation of certain prescription drugs from Canada under certain conditions.

State-licensed pharmacists and pharmacy interns will be able to order and administer coronavirus disease 2019 vaccines under certain conditions.

In the letter, NCPA stated that investigations should probe problems associated with mail order prescription plans.

NACDS is urging states to provide clarity on pharmacist-provided childhood vaccinations, and enhance overall patient access to vaccines.

Twelve pharmacy organization issued a joint statement in response to the expansion of the pharmacist's role in providing vaccines to children.

HHS authorized all state-licensed pharmacists to order and administer childhood vaccinations amid the coronavirus disease 2019 (COVID-19) pandemic.

NACDS is urging the Centers for Medicare & Medicaid Services (CMS) to change how pharmacy reimbursement rates are calculated for drug discount cards.

In an open letter, several health organizations urged the Trump Administration and Congress to recognize pharmacists as medical providers.

The state joins New York and Minnesota in providing COVID-19 vaccination access through pharmacy.

Here's this week's coronavirus-related news.

Eighty-one percent of opioid abuse referrals to post-acute care facilities in Massachusetts were rejected, investigators found.

In a letter to President Trump, NCPA CEO explained that failure to implement sweeping DIR fee reform would be detrimental to independent community pharmacies and their patients.

Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

“Telehealth has kept the entire health care system afloat and has enabled patients to continue to receive care,” the American Telemedicine Association’s president said in a testimony.

Until social distancing measures are phased out, store owners who want to make a difference in independent pharmacy can and should leverage technology to connect with legislators virtually.

New legislation authorizes licensed New York pharmacists to administer a vaccine for coronavirus disease 2019 (COVID-19) when it becomes available.

A new guidance from the US Department of Health & Human Services (HHS) paves the way for pharmacists nationwide to administer coronavirus disease 2019 (COVID-19) tests.

115 members of the House have come out in support of eliminating DIR fees in future coronavirus relief packages.

In a new lawsuit, CVS, Walgreen, Rite Aid, and other major pharmacy chains said that they are not to blame in federal opioid litigation